AVIR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient trader: momentum is modestly bullish, but the statistical forward-return outlook is negative over the next week (-2.64%) and month (-5.32%).", "Price (pre-market ~4.05) is above the pivot (3.901) but still below nearby resistance (R1 4.256), implying limited immediate upside versus meaningful downside to S1 (3.546).", "Intellectia Proprietary Trading Signals", "- AI Stock Picker: No signal on given stock today.", "- SwingMax: No signal on given stock today."]
["Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200 (uptrend intact).", "Momentum: MACD histogram positive (0.0355) but positively contracting \u2192 bullish momentum is fading rather than accelerating.", "RSI(6)=61.21: mildly bullish/neutral (not overbought), but not a strong breakout signal.", "Key levels: Pivot 3.901; Resistance R1 4.256 then R2 4.476; Support S1 3.546 then S2 3.326.", "Tactical read: Unless it clears and holds above ~4.26 (R1), the setup looks more like a range trade than a high-conviction chase."]
["Technicals remain in an uptrend (stacked bullish moving averages).", "Options market shows strong call skew (sentiment leaning bullish).", "Financial losses improved YoY in the latest quarter (narrowing losses)."]
["No news in the last week \u2192 no obvious near-term catalyst to push through resistance.", "Pattern-based forward outlook provided is negative over 1 week and 1 month (-2.64%, -5.32%).", "Company still has zero revenue (biotech development-stage profile) with ongoing sizable losses.", "No Intellectia buy signals today (no AI Stock Picker pre-market buy, no SwingMax entry).", "No notable hedge fund/insider trend; no recent congress trading data available."]
["Latest quarter: 2025/Q3.", "Revenue: 0 (no growth base; remains pre-commercial).", "Net income: -42.049M, improved ~34.98% YoY (loss narrowing).", "EPS: -0.53, improved ~43.24% YoY (still meaningfully negative).", "Overall: improving cost/loss profile, but still no revenue traction shown in the snapshot."]
["No analyst rating/price target change data was provided, so a trend summary cannot be confirmed from the dataset.", "Wall Street pros/cons view (based on available info only): Pros\u2014losses improving and technical trend is up; Cons\u2014no revenue, high uncertainty/IV, and no clear near-term catalyst."]
